Faculty

Back to Index
Anne Kathryn Schuckman, MD
Assistant Professor of Clinical Urology
Urology
NOR 7416 Health Sciences Campus Los Angeles
+1 323 865 3700

Overview

Dr. Anne Schuckman graduated from Stanford University, and completed her medical training at the University of Southern California School of Medicine. She completed her residency training at LAC+USC Medical Center and her fellowship in urologic oncology under Dr. Donald Skinner at USC Norris Comprehensive Cancer Center.

Dr. Schuckman’s areas if interest include testicular cancer, bladder cancer and urinary reconstruction. She performs both open and laparoscopic procedures, including laparoscopic nephrectomy and partial nephrectomy.

Awards

American Urological Association: Murphy Scholar, 2006

Publications

Baseline Glomerular Filtration Rate and Cisplatin- Induced Renal Toxicity in Urothelial Cancer Patients. Clin Genitourin Cancer. 2017 Sep 06. View in: PubMed

Current Management Strategy for Penile Cancer and Future Directions. Curr Oncol Rep. 2017 Aug; 19(8):54. View in: PubMed

90-Day complication rate in patients undergoing radical cystectomy with enhanced recovery protocol: a prospective cohort study. World J Urol. 2017 Jun; 35(6):907-911. View in: PubMed

Gastrointestinal Complications Following Radical Cystectomy Using Enhanced Recovery Protocol. Eur Urol Focus. 2017 Apr 25. View in: PubMed

Prospective Evaluation of Continence Following Radical Cystectomy and Orthotopic Urinary Diversion Using a Validated Questionnaire. J Urol. 2016 Dec; 196(6):1685-1691. View in: PubMed

90-Day complication rate in patients undergoing radical cystectomy with enhanced recovery protocol: a prospective cohort study. World J Urol. 2016 Oct 12. View in: PubMed

Epidermal Growth Factor Receptor, Excision-Repair Cross-Complementation Group 1 Protein, and Thymidylate Synthase Expression in Penile Cancer. Clin Genitourin Cancer. 2016 Oct; 14(5):450-456. e1. View in: PubMed

Postoperative Pain Management after Radical Cystectomy: Comparing Traditional versus Enhanced Recovery Protocol Pathway. J Urol. 2015 Nov; 194(5):1209-13. View in: PubMed

Urothelial carcinoma in bladder diverticula: outcomes after radical cystectomy. World J Urol. 2015 Oct; 33(10):1397-402. View in: PubMed

Ureteroenteric Strictures After Open Radical Cystectomy and Urinary Diversion: The University of Southern California Experience. Urology. 2015 Jul; 86(1):87-91. View in: PubMed

Venous thromboembolism following radical cystectomy: significant predictors, comparison of different anticoagulants and timing of events. J Urol. 2015 Feb; 193(2):565-9. View in: PubMed

Outcomes after urothelial recurrence in bladder cancer patients undergoing radical cystectomy. Urology. 2014 Dec; 84(6):1420-6. View in: PubMed

Significance of perivesical lymph nodes in radical cystectomy for bladder cancer. Urol Oncol. 2014 Nov; 32(8):1158-65. View in: PubMed

Hexaminolevulinate blue-light cystoscopy in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on appropriate use in the USA. Nat Rev Urol. 2014 Oct; 11(10):589-96. View in: PubMed

Level III-IV Inferior Vena Caval Thrombectomy Without Cardiopulmonary Bypass: Long-Term Experience with Intrapericardial Control. J Urol. 2014 Sep; 192(3):682-9. View in: PubMed

Level III-IV inferior vena caval thrombectomy without cardiopulmonary bypass: long-term experience with intrapericardial control. J Urol. 2014 Sep; 192(3):682-8. View in: PubMed

Enhanced recovery protocol after radical cystectomy for bladder cancer. J Urol. 2014 Jul; 192(1):50-6. View in: PubMed

Enhanced recovery protocol after radical cystectomy for bladder cancer. J Urol. 2014 Jul; 192(1):50-5. View in: PubMed

Clinicopathologic characteristics and outcomes of penile cancer treated at tertiary care centers in the Western United States. Clin Genitourin Cancer. 2014 Apr; 12(2):138-42. View in: PubMed

Impact of micropapillary urothelial carcinoma variant histology on survival after radical cystectomy. Urol Oncol. 2014 Feb; 32(2):110-6. View in: PubMed

Long-term cancer control after radical prostatectomy and bilateral pelvic lymph node dissection for pT3bN0M0 prostate cancer in the prostate-specific antigen era. Urol Oncol. 2014 Feb; 32(2):85-91. View in: PubMed

Epidermal Growth Factor Receptor-targeted Therapy in Squamous Cell Carcinoma of the Penis: A Report of 3 Cases. Urology. 2014 Jan; 83(1):159-66. View in: PubMed

The differential expression of EphB2 and EphB4 receptor kinases in normal bladder and in transitional cell carcinoma of the bladder. PLoS One. 2014; 9(8):e105326. View in: PubMed

Epidermal growth factor receptor-targeted therapy in squamous cell carcinoma of the penis: a report of 3 cases. Urology. 2014 Jan; 83(1):159-65. View in: PubMed

Effect of gender on outcomes following radical cystectomy for urothelial carcinoma of the bladder: a critical analysis of 1,994 patients. Urol Oncol. 2014 Jan; 32(1):52. e1-9. View in: PubMed

Neoadjuvant chemotherapy with gemcitabine/cisplatin vs. methotrexate/vinblastine/doxorubicin/cisplatin for muscle-invasive urothelial carcinoma of the bladder: a retrospective analysis from the University of Southern California. Urol Oncol. 2013 Nov; 31(8):1737-43. View in: PubMed

Factors influencing post-recurrence survival in bladder cancer following radical cystectomy. BJU Int. 2012 Mar; 109(6):846-54. View in: PubMed

Cardiopulmonary bypass and renal cell carcinoma with level IV tumour thrombus: can deep hypothermic circulatory arrest limit perioperative mortality? BJU Int. Cardiopulmonary bypass and renal cell carcinoma with level IV tumour thrombus: can deep hypothermic circulatory arrest limit perioperative mortality? BJU Int. 2011 Mar; 107(5):724-728. View in: PubMed

Cardiopulmonary bypass and renal cell carcinoma with level IV tumour thrombus: can deep hypothermic circulatory arrest limit perioperative mortality? BJU Int. Cardiopulmonary bypass and renal cell carcinoma with level IV tumour thrombus: can deep hypothermic circulatory arrest limit perioperative mortality? BJU Int. 2011 Mar; 107(5):724-8. View in: PubMed

Surgical considerations for elderly urologic oncology patients. Urol Oncol. 2009 Nov-Dec; 27(6):628-32. View in: PubMed

Powered bySC CTSI